Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MDRNA, Inc. Receives Full FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis; Par Pharmaceutical Companies, Inc. Launches Product
MDRNA, Inc. Receives Full FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis; Par Pharmaceutical Companies, Inc. Launches Product
MDRNA, Inc. Receives Full FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis; Par Pharmaceutical Companies, Inc. Launches Product
Submitted by
admin
on June 9, 2009 - 8:45am
Source:
Yahoo
News Tags:
Par Pharmaceutical
osteoporosis
FDA
ANDAs
Headline:
MDRNA, Inc. Receives Full FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis; Par Pharmaceutical Companies, Inc. Launches Product
Do Not Allow Advertisers to Use My Personal information
